Unknown

Dataset Information

0

Topically-applied collagen-binding serum albumin-fused interleukin-4 modulates wound microenvironment in non-healing wounds.


ABSTRACT: Non-healing wounds have a negative impact on quality of life and account for many cases of amputation and even early death among patients. Diabetic patients are the predominate population affected by these non-healing wounds. Despite the significant clinical demand, treatment with biologics has not broadly impacted clinical care. Interleukin-4 (IL-4) is a potent modulator of the immune system, capable of skewing macrophages towards a pro-regeneration phenotype (M2) and promoting angiogenesis, but can be toxic after frequent administration and is limited by its short half-life and low bioavailability. Here, we demonstrate the design and characterization of an engineered recombinant interleukin-4 construct. We utilize this collagen-binding, serum albumin-fused IL-4 variant (CBD-SA-IL-4) delivered in a hyaluronic acid (HA)-based gel for localized application of IL-4 to dermal wounds in a type 2 diabetic mouse model known for poor healing as proof-of-concept for improved tissue repair. Our studies indicate that CBD-SA-IL-4 is retained within the wound and can modulate the wound microenvironment through induction of M2 macrophages and angiogenesis. CBD-SA-IL-4 treatment significantly accelerated wound healing compared to native IL-4 and HA vehicle treatment without inducing systemic side effects. This CBD-SA-IL-4 construct can address the underlying immune dysfunction present in the non-healing wound, leading to more effective tissue healing in the clinic.

SUBMITTER: Lauterbach AL 

PROVIDER: S-EPMC10495343 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Topically-applied collagen-binding serum albumin-fused interleukin-4 modulates wound microenvironment in non-healing wounds.

Lauterbach Abigail L AL   Wallace Rachel P RP   Alpar Aaron T AT   Refvik Kirsten C KC   Reda Joseph W JW   Ishihara Ako A   Beckman Taryn N TN   Slezak Anna J AJ   Mizukami Yukari Y   Mansurov Aslan A   Gomes Suzana S   Ishihara Jun J   Hubbell Jeffrey A JA  

NPJ Regenerative medicine 20230911 1


Non-healing wounds have a negative impact on quality of life and account for many cases of amputation and even early death among patients. Diabetic patients are the predominate population affected by these non-healing wounds. Despite the significant clinical demand, treatment with biologics has not broadly impacted clinical care. Interleukin-4 (IL-4) is a potent modulator of the immune system, capable of skewing macrophages towards a pro-regeneration phenotype (M2) and promoting angiogenesis, bu  ...[more]

Similar Datasets

| S-EPMC4817982 | biostudies-literature
| S-EPMC9218655 | biostudies-literature
| S-EPMC6798797 | biostudies-literature
| S-EPMC8965477 | biostudies-literature
| S-EPMC7099415 | biostudies-literature
| S-EPMC5029898 | biostudies-literature
| S-EPMC8840736 | biostudies-literature
| S-EPMC4274809 | biostudies-literature
| S-EPMC4203321 | biostudies-literature
| S-EPMC7941746 | biostudies-literature